Offensive marketing strategies for switched non-prescription drugs eyed

Pharmaceutical industry sources say that the domestic drugs makers of digestives and antacids are intensifying their countermeasure strategies in marketing to minimize the impacts associated with the government's policy which switched more than 900 OTC drugs, including digestives and antacids, into non-prescription drugs last April.

Originally, the government predicted that if these OTCs in...